dc.contributor.author | Yilmaz, Vuslat | |
dc.contributor.author | Aysal, Fikret | |
dc.contributor.author | Deymeer, Feza | |
dc.contributor.author | Gulsen-Parman, Yesim | |
dc.contributor.author | Saruhan-Direskeneli, Güher | |
dc.contributor.author | Oflazer, Piraye | |
dc.contributor.author | Alahgholi-Hajibehzad, Mahdi | |
dc.date.accessioned | 2021-03-02T23:01:37Z | |
dc.date.available | 2021-03-02T23:01:37Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Alahgholi-Hajibehzad M., Yilmaz V., Gulsen-Parman Y., Aysal F., Oflazer P., Deymeer F., Saruhan-Direskeneli G., "Association of HLA-DRB1*14, -DRB1*16 and -DQB1*05 with MuSK-myasthenia gravis in patients from Turkey", Human Immunology, cilt.74, sa.12, ss.1633-1635, 2013 | |
dc.identifier.issn | 0198-8859 | |
dc.identifier.other | av_10031cd4-09f3-4740-b2d4-bbeba7c2ae59 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/16288 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84888201790&origin=inward | |
dc.identifier.uri | https://doi.org/10.1016/j.humimm.2013.08.271 | |
dc.description.abstract | Susceptibility to myasthenia gravis (MG) has been demonstrated with several HLA in different disease subgroups. HLA-DR14, -DR16 and -DQ5 were reported as predisposing factors in muscle-specific kinase antibody positive MG (MuSK-MG). These markers were evaluated in MG subgroups from Turkey. Among 164 generalized MG patients, 116 had antibodies against anti-acetylcholine receptor (AChR-MG) and 48 had MuSK-MG. Only HLA-DRB1 and DQB1 allele groups reported to be associated with MuSK-MG were compared with 250 healthy controls (HC). Highly significant associations of both DRB1*16 and DRB1*14 were found with MuSK-MG compared to HC (p=1.9×10-5, OR: 4.95 and p=0.0028, OR: 3.1). On the contrary, HLA-DRB1*03 was less frequent in MuSK-MG (p=0.006, OR: 0.09). DQB1*05 was also associated with MuSK-MG (p=2.5×10-6 OR: 4.8). This study provides a replication of the highly significant associations of both HLA-DRB1*16,-DRB1*14 and -DQB1*05 with MuSK-MG. Moreover, HLA-DRB1*03 appears to have a distinguishing role for this disease subgroup compared to early-onset and AChR-MG. © 2013 American Society for Histocompatibility and Immunogenetics. | |
dc.language.iso | eng | |
dc.subject | İmmünoloji | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.title | Association of HLA-DRB1*14, -DRB1*16 and -DQB1*05 with MuSK-myasthenia gravis in patients from Turkey | |
dc.type | Makale | |
dc.relation.journal | Human Immunology | |
dc.contributor.department | Istanbul Bakirkoy Mental Health & Neurology Training & Research Hospital , , | |
dc.identifier.volume | 74 | |
dc.identifier.issue | 12 | |
dc.identifier.startpage | 1633 | |
dc.identifier.endpage | 1635 | |
dc.contributor.firstauthorID | 24281 | |